|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61K 31/538 | |||
| A61P 11/00 |
| (11) | Number of the document | 3551187 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17811550.7 |
| Date of filing the European patent application | 2017-12-06 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/081691 |
| Date | 2017-12-06 |
| (87) | Number | WO 2018/108669 |
| Date | 2018-06-21 |
| (30) | Number | Date | Country code |
| 16203359 | 2016-12-12 | EP |
| (72) |
WOLLIN, Stefan, DE
WEX, Eva, DE
HERRMANN, Franziska, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL |
| NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL |